Title List مقالات لاتين Pharmacokinetic Studies on Oximes in Organophosphate Poisoning: A Mini Review Phase change materials based on low-density polyethylene/paraffin wax blends

بر اساس عنوان

1

Pharmacokinetic Studies on Oximes in Organophosphate Poisoning: A Mini Review

2

Pharmacokinetic Study of a Capsule-based Chronomodulated Drug Delivery System of Salbutamol Sulphate in Rabbits

3

Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species

4

Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography–tandem mass spectrometry

5

Pharmacokinetic study of carbamazepine and its carbamazepine 10,11-epoxide metabolite in a group of female epileptic patients under chronic treatment

6

PHARMACOKINETIC STUDY OF CEPHRADINE IN PAKISTANI HEALTHY MALE VOLUNTEERS

7

Pharmacokinetic study of dicloxacillin sodium following intravenous and intramuscular administration to pigs

8

Pharmacokinetic study of dl-tetrahydropalmatine patches by UPLC–MS/MS in rabbits

9

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract

10

Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry

11

Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat

12

Pharmacokinetic study of HS061, a new human insulin, in non-diabetic rat using ultra performance liquid chromatography–tandem mass spectrometry

13

Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography

14

Pharmacokinetic study of mangiferin in human plasma after oral administration

15

Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose

16

Pharmacokinetic study of multiple active constituents from Kushen–Gancao Decoction after oral administration in rat by HPLC–MS/MS

17

Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.

18

Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers

19

Pharmacokinetic study of niosome-loaded insulin in diabetic rats

20

Pharmacokinetic study of orphenadrine using high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS)

21

Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride

22

Pharmacokinetic variability of extended interval tobramycin in burn patients

23

PHARMACOKINETIC VARIATIONS OF OFLOXACIN IN NORMAL AND FEBRILE RABBITS

24

Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies

25

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients

26

Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes

27

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology

28

Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens

29

Pharmacokinetic-Pharmacodynamic Modeling: Why?

30

Pharmacokinetic–pharmacodynamic models for categorical toxicity data

31

Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep

32

Pharmacokinetics after pulmonary artery perfusion with gemcitabine

33

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients

34

Pharmacokinetics and Bioavailability Comparison of two oral Tablet Formulations of Escitalopram 20 mg: A Single-Dose, Open-Label, Two-Period Crossover Study in Healthy Indian Adult Subjects

35

Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application

36

Pharmacokinetics and bioavailability study of polydatin in rat plasma by using a LC–MS/MS method

37

Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice

38

Pharmacokinetics and Biodistribution of Rhopalurus junceus Scorpion Venom in Tumor-Bearing Mice after Intravenous and Oral Administration

39

Pharmacokinetics and Bioequivalence of Methotrexate in Human Plasma Studied by Liquid Chromatography-Mass Spectrometry (LC-MS)

40

Pharmacokinetics and Bioequivalence Study of Two Formulations of Cefixime in Healthy Male Volunteers

41

Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography Original Research Article

42

Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant

43

Pharmacokinetics and Dosage Regimen of Cefepime following Single Dose Intravenous Administration in Calves

44

Pharmacokinetics and Dosage Regimen of Cefpirome in Febrile Cross-Bred Calves

45

PHARMACOKINETICS AND DOSAGE REGIMEN OF CIPROFLOXACIN FOLLOWING SINGLE INTRAMUSCULAR ADMINISTRATION IN TEDDY GOATS

46

Pharmacokinetics and dosimetry of 188Re-pharmaceuticals

47

Pharmacokinetics and Effects of Alkalization after Intravenous Administration of Eltenac in Horses

48

Pharmacokinetics and Effects of Alkalization During Oral and Intravenous Administration of Naproxen in Horses

49

Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity

50

Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogs

51

Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease

52

Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids

53

Pharmacokinetics and excretion study of sophoricoside and its metabolite in rats by liquid chromatography tandem mass spectrometry

54

Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure

55

Pharmacokinetics and hepatotoxicity of diclofenac using an isolated perfused rat liver

56

Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatine nanoformulation designed for parenteral administration for the treatment of malaria

57

Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans

58

Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius)

59

Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses

60

Pharmacokinetics and metabolism of 3,4-dichlorophenyl-propenoyl-sec.-butylamine in rats by high performance liquid chromatography–ion trap mass spectrometry

61

Pharmacokinetics and metabolism of single oral doses of trovafloxacin

62

Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction

63

Pharmacokinetics and metabolite identification of a novel VEGFR-2 and Src dual inhibitor 6-chloro-2-methoxy-N-(2-methoxybenzyl) acridin-9-amine in rats by liquid chromatography tandem mass spectrometry

64

Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats

65

Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats

66

Pharmacokinetics and Molecular Docking Studies of Uridine Derivatives as SARSCOV-2 Mpro Inhibitors

67

Pharmacokinetics and Pharmacodynamic Effects of Flunixin after Intravenous, Intramuscular and Oral Administration to Dairy Goats

68

Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses

69

Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses

70

Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats

71

Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors

72

Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy

73

Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements

74

Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites

75

Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy

76

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy

77

Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy

78

Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids

79

Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-image-tyrosine as oncologic PET tracer

80

Pharmacokinetics and residual behaviour in milk of oxytetracycline in cows following administration of uterine pessaries

81

Pharmacokinetics and residues of a new oral amoxicillin formulation in piglets: A preliminary study

82

Pharmacokinetics and residues of tetracycline in crucian carp muscle using capillary electrophoresis on-line coupled with electrochemiluminescence detection

83

Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass

84

Pharmacokinetics and tissue and milk disposition of Tilmicosin in sheep after single administrations

85

Pharmacokinetics and tissue distribution of a novel marine fibrinolytic compound in Wistar rat following intravenous administrations

86

Pharmacokinetics and Tissue Distribution of Antimony(v) after Multiple Intramuscular Administrations in the Hamster

87

Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy

88

Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography–mass spectrometry: Evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier

89

Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice

90

Pharmacokinetics and Tolerability of Iopromide 240 After Lumbar Myelography

91

Pharmacokinetics in gene delivery

92

Pharmacokinetics in pregnancy

93

Pharmacokinetics in the elderly

94

Pharmacokinetics in the newborn

95

Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses

96

Pharmacokinetics of a Mono-pyridinium-mono-aldoxime (K-347), a Potential Antidote in Organophosphate Poisoning

97

Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat

98

Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats

99

Pharmacokinetics of alprazolam in elderly patients with multiple diseases

100

Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design

101

Pharmacokinetics of Amoxicillin/Clavulanic Acid Combination after Oral Administration of New Suspension Formulations in Human Volunteers

102

Pharmacokinetics of an ampicillin–sulbactam combination after intravenous and intramuscular administration to neonatal calves

103

Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors

104

Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration

105

Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs

106

PHARMACOKINETICS OF CALCIUM FROM CALCIUM SUPPLEMENTS IN HEALTHY VOLUNTEERS

107

Pharmacokinetics of calycopterin and xanthmicrol, two polymethoxylated hydroxyflavones with anti-angiogenic activities from Dracocephalum kotschyi Bioss

108

Pharmacokinetics of Cefepime Following Intravenous and Intramuscular Administration in Sheep

109

Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats

110

Pharmacokinetics of ceftazidime in buffalo calves following intravenous and intramuscular administration

111

Pharmacokinetics of ceftiofur sodium in equine pregnancy

112

Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration

113

Pharmacokinetics of Cephalexin in the Horse After Intravenous and Intramuscular Administration of Two Formulations

114

Pharmacokinetics of ciprofloxacin in bath medicated hybrid tilapias using enzyme linked immunosorbent assay (ELISA)

115

PHARMACOKINETICS OF CIPROFLOXACIN IN NORMAL RABBITS AND CHANGES OBSERVED IN INDUCED DEHYDRATED STATE

116

Pharmacokinetics of ciprofloxacin in sheep following intravenous and subcutaneous administration

117

Pharmacokinetics of ciprofloxacin in the rat and its interaction with cyclosporin A: a microdialysis study Original Research Article

118

Pharmacokinetics of Clozapine: An Investigate the Potential Molecular Mechanisms of Action

119

Pharmacokinetics of combined doxorubicin and paclitaxel in mice

120

Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin

121

Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats

122

Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in broiler chickens

123

Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in pigs

124

Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects

125

Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis

126

Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration

127

Pharmacokinetics of Diclofenac in Sheep Following Intravenous and Intramuscular Administration

128

Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis

129

Pharmacokinetics of Doramectin and Ivermectin After Oral Administration in Horses*

130

Pharmacokinetics of doramectin in lactating dairy sheep and suckling lambs Original Research Article

131

Pharmacokinetics of doxycycline in sheep after intravenous and oral administration

132

Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits

133

Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin and Its Interaction With Diclofenac After Intravenous Administration in Buffalo Calves

134

Pharmacokinetics of Enrofloxacin and its Metabolite Ciprofloxacin in Goats given Enrofloxacin Alone and in Combination with Probenecid

135

Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves

136

Pharmacokinetics of ergosterol in rats using rapid resolution liquid chromatography–atmospheric pressure chemical ionization multi-stage tandem mass spectrometry and rapid resolution liquid chromatography/tandem mass spectrometry

137

Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats

138

Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization

139

Pharmacokinetics of fexofenadine in healthy Taiwanese volunteers

140

Pharmacokinetics of fleroxacin in horses

141

Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma

142

Pharmacokinetics of gadoversetamide injection, a gadolinium-based contrast agent, in pediatric patients

143

Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography–tandem mass spectrometry

144

Pharmacokinetics of Gefodizime in Patients with Various Degrees of Renal Failure

145

Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation

146

Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs

147

Pharmacokinetics of HZ08 in rats by liquid chromatography–tandem mass spectrometry

148

Pharmacokinetics of ingested fluoride: Lack of effect of chemical compound

149

Pharmacokinetics of Intravascularly Administered 65Zinc in Channel Catfish (Ictalurus punctatus)

150

Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles

151

Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia

152

Pharmacokinetics of kadsurenone and its interaction with cyclosporin A in rats using a combined HPLC and microdialysis system

153

Pharmacokinetics of kakkalide and its main metabolites in rat plasma determined by HPLC-DAD and LC–MSn

154

Pharmacokinetics of ketoprofen enantiomers after intravenous administration of racemate in camels: effect of gender

155

Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia

156

Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression

157

Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging

158

Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches

159

Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats

160

Pharmacokinetics of melamine in pigs following intravenous administration

161

Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs

162

Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration

163

Pharmacokinetics of metronidazole in rat blood, brain and bile studied by microdialysis coupled to microbore liquid chromatography

164

Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates

165

Pharmacokinetics of Mirtazapine and Its Main Metabolites after Single Oral Administration in Fasting/Fed Horses

166

Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study

167

Pharmacokinetics of oral gabapentin alone or co-administered with meloxicam in ruminant beef calves

168

Pharmacokinetics of oral gabapentin in greyhound dogs

169

Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy, , ,

170

Pharmacokinetics of pefloxacin mesylate in human urine using capillary electrophoresis electrochemiluminescence detection

171

Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats

172

Pharmacokinetics of piperine after oral administration of Sahastara remedy capsules in healthy volunteers

173

Pharmacokinetics of prostaglandins

174

Pharmacokinetics of protein-unbound linezolid in the blood and the mechanism of hepatobiliary excretion in the rat Original Research Article

175

Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC–tandem mass spectrometry

176

Pharmacokinetics of sodium and trihydrate amoxicillin after intravenous and intramuscular administration in llamas (Lama glama)

177

Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice

178

Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus conventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice

179

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies

180

Pharmacokinetics of Sulpiride After Intravenous, Intramuscular, and Oral Single-Dose Administration in Nurse Mares

181

Pharmacokinetics of Tetracycline and Tetracycline Loaded Nanoemulsion Formula in Rabbits

182

Pharmacokinetics of tetracycline hydrochloride in fat-tailed sheep

183

Pharmacokinetics of the low molecular weight heparin dalteparin in cats

184

Pharmacokinetics of the novel atypical opioid tapentadol after intravenous, intramuscular and subcutaneous administration in cats

185

Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs

186

Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP5+, in plasma and major organs of B6C3F1 mice

187

Pharmacokinetics of the Thymidine Analog 2-Fluoro-5[14C]-methy1-1-beta-D-arabinofuranosyluracil ([14C]FMAU) in Rat Prostate Tumor Cells

188

Pharmacokinetics of tobramycin in ducks and sex-related differences

189

Pharmacokinetics of Tramadol after Epidural Administration in Horses

190

Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration

191

Pharmacokinetics of Tramadol and Its Metabolites M1, M2, and M5 in Donkeys after Intravenous and Oral Immediate Release Single-Dose Administration

192

Pharmacokinetics of tulathromycin in lactating goats

193

Pharmacokinetics of two different delivery regimens of doxorubicin in isolated hyperthermic limb perfusion

194

PHARMACOKINETICS OF UMF-078, A CANDIDATE ANTIFILARIAL DRUG, IN INFECTED DOGS

195

Pharmacokinetics of zonisamide in perinatal period

196

Pharmacokinetics Studies of some Diaryl Pyrimidinamine Derivatives as Anti-Cancer Agent: In-Silico Drug Design and Molecular Docking

197

Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine

198

Pharmacokinetics, bioavailability and tissue residues of [14C]isometamidium in non-infected and Trypanosoma congolense-infected Boran cattle

199

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel

200

Pharmacokinetics, dosage regimen and in vitro plasma protein binding of intramuscular levofloxacin in buffalo calves

201

Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl

202

Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes l-methioninase

203

Pharmacokinetics, pharmacodynamics and toxicity of a combination of metoprolol succinate and telmisartan in Wistar albino rats: Safety profiling

204

Pharmacokinetics, safety, and effects on exercise performance of l-arginine α-ketoglutarate in trained adult men

205

Pharmacokinetics, tissue distribution and excretion of a new photodynamic drug deuxemether

206

Pharmacokinetics, tissue distribution and excretion study of dictamnine, a major bioactive component from the root bark of Dictamnus dasycarpus Turcz. (Rutaceae)

207

Pharmacokinetics, urinary excretion and plasma protein binding of 2,3-butanedione monoxime in goats

208

Pharmacokinetics, urinary excretion and plasma protein binding of pralidoxime in goats

209

Pharmacokmetics and oral bioavailability of a doxycycline formulation (DOXYCYCLINE 75%) in nonfasted young pigs

210

Pharmacokmetics and oral bioavailability of a doxycycline formulation (DOXYCYCLINE 75%) in nonfasted young pigs

211

Pharmacoligical characterization of the iranian Cerastes cerastes gasperettii (Reptilia: Ophidia: Viperidae) venom

212

Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription

213

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

214

Pharmacologic agents for the treatment of acute bipolar mania

215

Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration Evidence of fully excitable gap in the reentrant circuit

216

Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches

217

Pharmacologic and Therapeutic Differences Among Calcium Channel Antagonists: Profile of Mibefradil, a New Calcium Antagonist

218

Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease

219

Pharmacologic approaches to rhythm versus rate control in atrial fibrillation—where are we now?

220

Pharmacologic approaches to therapy for vasovagal syncope

221

Pharmacologic Characterization of Wool Dust Extract in Isolated Guinea Pig Trachea

222

Pharmacologic evidence for a parasympathetic role in seizure-induced neurocardiac regulatory abnormalities

223

Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

224

Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

225

Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage

226

Pharmacologic management of childhood hypertension: current status, future challenges

227

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

228

Pharmacologic modulation of neutrophil functions

229

Pharmacologic modulation of the collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis

230

Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: Impact on hemodynamic function and left ventricular performance

231

Pharmacologic myocardial regeneration

232

Pharmacologic Options for Aggressive Low-Density Lipoprotein Cholesterol Lowering: Benefits Versus Risks

233

Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes

234

Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty

235

Pharmacologic preservation of the hemostatic system during cardiac surgery

236

Pharmacologic prevention of poterior capule opacification: in vitro effect of preervative-free lidocaine 1 % on len epithelial cell

237

Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals

238

Pharmacologic Prophylaxis and Treatment of Venous Thromboembolism after Knee Arthroplasty

239

Pharmacologic Relevance of K+Channel Remodeling in Atrial Fibrillation

240

Pharmacologic strategies for augmenting cognitive performance in schizophrenia

241

Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery

242

Pharmacologic stress echocardiography: can we forget “state-of-the-art” protocols?

243

Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis

244

Pharmacologic stress-induced regional myocardial blood flow heterogeneity and left ventricular wall thickening abnormality: Comparison of intravenous adenosine with dipyridamole in a model of critical coronary stenosis, , ,

245

Pharmacologic support with high-energy phosphate preservation in the postischemic neonatal heart

246

Pharmacologic therapies after myocardial infarction

247

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

248

Pharmacologic treatment of atherosclerosis: beyond lipid-lowering therapy

249

Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996

250

Pharmacologic treatment of schizophrenia

251

Pharmacologic Treatment of Wet Type Age-related Macular Degeneration; Current and Evolving Therapies

252

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma

253

Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation

254

Pharmacologic versus flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans

255

Pharmacologic Vitreolysis

256

Pharmacological Action of Mentha piperita on Lipid Profile in Fructose-Fed Rats

257

Pharmacological action of tick saliva upon haemostasis and the neutralization ability of sera from repeated infested hosts

258

Pharmacological Activities of Hypnea musciformis

259

Pharmacological activity of 2% aqueous acetic acid extract of Alhagi maurorum roots

260

Pharmacological algorithms for treatment resistant depression in children and adolescents

261

Pharmacological analysis of ovarial patency in Heliothis virescens

262

Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac)

263

Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats

264

Pharmacological and biological evaluation of extracts from Gratiola officinalis L. (Scrophulariaceae)

265

Pharmacological and cognitive-behavioral approaches in the treatment of childhood depression: A review and critique

266

Pharmacological and computational evaluation of Sapodilla and its constituents for therapeutic potential in hyperactive gastrointestinal disorders

267

Pharmacological and Medical Effect of Modified Skin Grafting Method in Patients with Chronic and Severe Neck Burns

268

Pharmacological and Medicinal Aspects of the Verses Containing Fig (At-tin) in Holy Quran

269

Pharmacological and Medicinal Aspects of the Verses Containing Fig (At-tin) in Holy Quran

270

Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder

271

Pharmacological and Molecular Evidence of Neuroprotective Curcumin Effects Against Biochemical and Behavioral Sequels Caused by Methamphetamine: Possible Function of CREB-BDNF Signaling Pathway

272

Pharmacological and non- pharmacological treatment of hypertension: A review article

273

Pharmacological and non-pharmacological means for prevention of fractures among elderly

274

Pharmacological and Nonpharmacological Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery

275

Pharmacological and Nonpharmacological Studies on Coronavirus Disease 2019: A Mini‑review of the Recent Evidence

276

Pharmacological and Non-pharmacological Therapeutic Strategies for Improvement of State-Trait Anxiety: A Randomized Controlled Trial Among Iranian Infertile Women With Sexual Dysfunctions

277

Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician

278

Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists Original Research Article

279

Pharmacological and Radiological Study of Patients with COVID-19 in Iran

280

Pharmacological and surgical treatments for obesity

281

Pharmacological and toxicity effects of Zhumeria majdae and its bioactive constituents: A review

282

Pharmacological and toxicity studies of the crude extracts and fractions of Hedranthera barteri leaf in rats and mice

283

Pharmacological and toxicological insights to the South African Amaryllidaceae

284

Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways

285

Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article

286

Pharmacological Approach for Prevention of Bleomycin-Induced Lung Injury

287

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis

288

Pharmacological approaches to discovery and development of new mucolytic agents

289

Pharmacological Aspects of Phyllanthus fraternus Standardized Extract (Rich in Lignans and Tannins) as a Pain Modulator

290

Pharmacological blockade of gap junctions induces repetitive surging of extracellular potassium within the locust CNS

291

Pharmacological chaperones and lysosomal storage diseases

292

Pharmacological characterisation of 5-hydroxytryptamine-induced contractile effects in the isolated gut of the lepidopteran caterpillar Spodoptera frugiperda

293

Pharmacological characterisation of extraneuronal transmitter store in porcine and human coronary arteries

294

Pharmacological Characterization of A2-Adenosine Receptors in Guinea-pig Ventricular Cardiomyocytes

295

Pharmacological Characterization of Effects of UK-1745, a Novel Cardiotonic Agent withβ-Adrenoceptor-blocking Action, in Aequorin-loaded Canine Right Ventricular Muscle

296

Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice

297

Pharmacological characterization of micropatterned cardiac myocytes

298

Pharmacological characterization of new β-agonists using Huβ1- and Huβ2-adrenergic receptor binding assay in transfected HEK-293 cells Original Research Article

299

Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells

300

Pharmacological Concepts of Temperament in Iranian Traditional Medicine

301

Pharmacological control of bleeding during cardiac surgery

302

Pharmacological control of periodontal disease. II. Antimicrobial agents

303

Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs

304

Pharmacological Correction of Early Embryogenesis Disorders in Cows

305

Pharmacological Differences of Glitazones: Does Peroxisome Proliferator-Activated Receptor-α Activation Make the Difference?

306

Pharmacological dissociation of autonomic and behavioural responses to fear in the medullary raphe

307

Pharmacological Effect of Caffeine on Drosophila melanogaster: A Proof-of-Concept in vivo Study for Nootropic Investigation

308

Pharmacological effects of a synthetic quinoline, a hybrid of tomoxiprole and naproxen, against acute pain and inflammation in mice: a behavioral and docking study

309

Pharmacological effects of biotin

310

Pharmacological effects of gallic acid in health and diseases: A mechanistic review

311

Pharmacological effects of low- dose of aspirin on Corpus Luteum functions in mature cycling female mice

312

Pharmacological effects of low- dose of aspirin on ovulation rate in mature cycling female mice

313

Pharmacological Effects of Origanum Vulgare L. in the Elevated Plus-Maze and Open Field Test in the Rat

314

Pharmacological Effects of Peganum harmala Seeds Extract on Isolated Rat Uterus

315

Pharmacological Effects of Rosa Damascena

316

Pharmacological effects of Safranal: An updated review

317

Pharmacological effects of tiludronate in horses after long-term immobilization

318

Pharmacological Effects on Brain Morphology and Cognitive Functions in Idiopathic Generalized Epilepsy

319

Pharmacological enhancement of cutaneous flap survival with topical dimethyl sulphoxide and hydrogen peroxide

320

Pharmacological Evaluation and Synthesis ofNewSulfonamides Derivatives Based on 1,4-Benzodioxane

321

Pharmacological evaluation of [11c]donepezil as tracer for visualization of acetylcholinesterase by PET

322

Pharmacological evaluation of a diarylmethylene-piperidine derivative: a new potent atypical antipsychotic?

323

Pharmacological evaluation of anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (water, ethyl acetate, and n-hexane fractions): the potential medicinal plants from North Sumatra, Indonesia

324

Pharmacological evaluation of combined PGI2 agonists/thromboxane synthase inhibitors. I

325

Pharmacological Evaluation of Covid 19 Vaccine in Acute and Chronic Inflammatory Neuropathies

326

Pharmacological Evaluation of Ng5 and Ng5* Newly Synthesized Derivates of Heteroaryl-Amino-Ethanols

327

Pharmacological Evaluation of Oral Hypoglycemic and Antidiabetic Effects of Fresh Leaves Ethanol Extract of Morinda Lucida Benth. in Normal and Alloxan-Induced Diabetic Rats

328

Pharmacological Evaluation of Sedative activity of methanolic extract of Thuja occidentalis in mice.

329

Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential

330

Pharmacological Evaluation of Selected Medicinal Plants Used in the Management of Oral and Skin Infections in Ebem-Ohafia District, Abia State, Nigeria

331

Pharmacological evaluation of tea polysaccharides with antioxidant activity in gastric cancer mice

332

Pharmacological evaluation of the semi-purified fractions from the soft coral Eunicella singularis and isolation of pure compounds

333

Pharmacological evaluation of UK-14,304 analogs at cloned human α adrenergic receptors

334

Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues

335

Pharmacological evidence for curcumin neuroprotective effects against lead-stimulated neurodegeneration: possible role of Akt/GSK3 signaling pathway

336

Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt- 1/GSK3 and CREB-BDNF signaling pathways

337

Pharmacological evidence for activation of phospholipid and small GTP binding protein signalling cascades by Nod factors

338

Pharmacological Evidence That Multiple Phospholipid Signaling Pathways Link Rhizobium Nodulation Factor Perception in Medicago truncatula Root Hairs to Intracellular Responses, Including Ca^2+ Spiking and Specific ENOD Gene Expression

339

Pharmacological Evidences for the Antiamnesic Effects of Desmodium gangeticum in mice

340

Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus

341

Pharmacological Hypotension as a Cause of Delirious Mania ina Patient with Bipolar Disorder

342

Pharmacological implications of lengthened in-utero exposure to nevirapine Original Research Article

343

Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression

344

Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein

345

Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein

346

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas

347

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity Original Research Article

348

Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines

349

Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model

350

Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress

351

Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro

352

Pharmacological intervention of traditional Chinese medicine for the quality of life in patients with colorectal cancer: a systematic review and metaanalysis

353

PHARMACOLOGICAL INTERVENTIONS FOR GERIATRIC CACHEXIA: A NARRATIVE REVIEW OF THE LITERATURE

354

Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?

355

PHARMACOLOGICAL INVESTIGATION OF CASSIA SOPHERA, LINN. VAR. PURPUREA, ROXB

356

Pharmacological management of interferon-induced psychiatric disorders

357

Pharmacological management of metabolic syndrome and its lipid complications

358

Pharmacological management of mild or moderate persistent asthma

359

Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches

360

Pharmacological management of tics in patients with TS

361

Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion

362

Pharmacological modulation of the hyperpolarization-activated current (If) in human atrial myocytes: focus on G protein-coupled receptors

363

Pharmacological modulation of wound healing in experimental burns

364

Pharmacological outcomes in newly diagnosed epilepsy

365

Pharmacological outcomes in older people with newly diagnosed epilepsy

366

Pharmacological outcomes in people with mental retardation and epilepsy

367

PHARMACOLOGICAL PAIN RELIEF IN PEDIATRIC PATIENTS

368

Pharmacological postconditioning with the phytoestrogen genistein

369

Pharmacological potential of ferulic acid for the treatment of metabolic syndrome and its mechanism of action: Review

370

Pharmacological Potential of Some Indonesian Medicinal Plants as Promising Options for COVID-19 During the Pandemic Era: A Literature Review

371

Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia

372

Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole

373

Pharmacological preconditioning with angiotensin converting enzyme inhibitors

374

Pharmacological preconditioning with angiotensin converting enzyme inhibitors; infarct size study

375

PHARMACOLOGICAL PRECONDITIONING WITH L-CARNITINE: RELEVANCE TO MYOCARDIAL HEMODYNAMIC FUNCTION AND GLYCOGEN AND LACTATE CONTENT

376

Pharmacological preconditioning with the adenosine triphosphate–sensitive potassium channel opener pinacidil

377

Pharmacological prevention of breast cancer: Quo Vadis?

378

Pharmacological prevention of breast cancer: Quo vadis?

379

Pharmacological prevention of prematurity

380

Pharmacological prevention of suicide in bipolar patients — A realizable target

381

Pharmacological Profile for the Contribution of NO/cGMP Pathway on Chlorpheniramine Antidepressant-Like Effect in Mice Forced Swim Test

382

Pharmacological profile of a nitric oxide donor spermine NONOate in the mouse corpus cavernosum

383

Pharmacological Profile of Oxazine and its Derivatives: A Mini Review

384

PHARMACOLOGICAL PROFILE OF SALVADORA PERSICA

385

Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals

386

Pharmacological Properties of Combination Therapies for Hypertension

387

Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats

388

Pharmacological properties of fucose. Applications in age-related modifications of connective tissues

389

Pharmacological properties of serotonin receptor subtypes mediating contraction of bovine inferior alveolar arteries

390

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

391

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

392

Pharmacological Properties of Vochysia Haenkeana (Vochysiaceae) Extract to Neutralize the Neuromuscular Blockade Induced by Bothropstoxin-I (Lys49 Phospholipase A2) Myotoxin

393

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

394

Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors

395

Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX

396

Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress

397

Pharmacological research in pediatrics: From neonates to adolescents

398

Pharmacological salvage of a combined distal bypass and free flap with catheter-directed thrombolysis

399

Pharmacological Screening of Annona Muricata: A Review

400

Pharmacological spinal cord protection with magnesium during replacement of the thoracic and thoracoabdominal aorta

401

Pharmacological strategies for blood loss

402

Pharmacological strategies for blood loss

403

Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints

404

Pharmacological stress agents for evaluation of ischemic heart disease

405

Pharmacological Studies on Khamira Marwarid: Effect on Pentylenetetrazole-Induced Seizures, Cognition and Biochemical Markers in Mice

406

Pharmacological Studies on Tetracycline and Tetracycline Nanoemulsion Formulas

407

Pharmacological study of signal transduction during stimulation of prothoracic glands from Manduca sexta

408

Pharmacological Study of the Antitumor Effect of Newcastle Oncolytic Virus in Combination with Copper Nanoparticles, Hyperthermia and Radiation on Malignant Colorectal Cancer Cell Line

409

Pharmacological therapies in fibromyalgia

410

Pharmacological therapy of osteoarthritis

411

Pharmacological therapy of Pagetʹs and other metabolic bone diseases

412

Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature

413

Pharmacological treatment

414

Pharmacological treatment effects on eye movement control

415

Pharmacological Treatment in Behavioural Medicine

416

Pharmacological Treatment in Behavioural Medicine: The Importance of Neurochemistry, Molecular Biology and Mechanistic Hypotheses

417

Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?

418

Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004

419

Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response

420

Pharmacological treatment of chronic constipation: a literature review

421

Pharmacological treatment of established rheumatoid arthritis

422

Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain

423

Pharmacological treatment of hepatorenal syndrome: A note of optimism

424

Pharmacological treatment of multi-organ bodily distress syndrome: A double-blind, placebo-controlled trial of the effects of imipramine (stress-3)

425

Pharmacological treatment of portal hypertension: present and future

426

Pharmacological treatment of systolic heart failure

427

Pharmacological treatment of systolic heart failure

428

PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION an‎d AWARENESS IN CORONARY ARTERY an‎d CEREBROVASCULAR DISEASE PATIENTS

429

PHARMACOLOGICAL TREATMENT, LIFESTYLE MODIFICATION AND AWARENESS IN CORONARY ARTERY AND CEREBROVASCULAR DISEASE PATIENTS

430

Pharmacological washout for the correct evaluation of the head-up tilt testing

431

Pharmacologically active microcarriers releasing glial cell line – derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats

432

Pharmacologically active microcarriers: a tool for cell therapy

433

Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection

434

Pharmacologically Relevant Drug Interactions of Nitrovasodilators

435

Pharmacologically relevant drug interactions of sulfonylurea antidiabetics with common herbs

436

Pharmacologically relevant drug interactions of sulfonylurea antidiabetics with common herbs

437

Pharmacologically tunable polyethylene-glycol-based cell growth substrate

438

Pharmacology – Prep Manual for Undergraduates

439

Pharmacology and clinical efficacy of angiotensin receptor blockers

440

Pharmacology and controlled release of hirudin for cardiovascular disorders

441

Pharmacology and Drug Interaction Effects of the Phosphodiesterase 5 Inhibitors: Focus on α-Blocker Interactions

442

Pharmacology and efficacy of cyclooxygenase (COX) inhibitors

443

Pharmacology and immunology of botulinum toxin type A

444

Pharmacology and medicines management for nurses (third edition),: George Downie, Jean Mackenzie and Arthur Williams (editors)Edinburgh, Churchill Livingstone, 2003, ISBN 0443071764, Pages 600, Price £22.99

445

Pharmacology and metabolism of alcohol, including its metabolic effects and interactions with other drugs

446

Pharmacology and phytochemistry studies in Peltophorum africanum

447

Pharmacology and Therapeutics: Principles to Practice

448

Pharmacology and Toxicology of Ethinyl Estradiol and Norethindrone Acetate in Experimental Animals

449

Pharmacology and Toxicology of Leflunomide

450

Pharmacology education: a theoretical framework of applied pharmacology and therapeutics

451

Pharmacology for midwives. The evidence base for safe practice: Sue Jordan; Palgrave Macmillan, Hampshire, UK, 512pp., price £20.99 paperback, ISBN 0333693965

452

Pharmacology of antiepileptic drugs during pregnancy and lactation

453

Pharmacology of Borage (Borago officinalis L.) Medicinal Plant

454

Pharmacology of carbon nanotubes: Toxicokinetics, excretion and tissue accumulation

455

Pharmacology of carvedilol

456

Pharmacology of coronary artery bypass grafts

457

Pharmacology of drugs used in neuroanaesthesia

458

Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data, ,

459

Pharmacology of Free Radicals and the Impact of Reactive Oxygen Species on the Testis

460

Pharmacology of local anaesthesia in different age groups

461

Pharmacology of modern volatile anaesthetics

462

Pharmacology of New Agents for Acute Heart Failure Syndromes

463

Pharmacology of new aromatase inhibitors

464

Pharmacology of nitrous oxide

465

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy

466

Pharmacology of serotonin-induced salivary secretion in Periplaneta americana

467

Pharmacology of skin aging. Stimulation of glycosaminoglycan biosynthesis by L-fucose and fucose-rich polysaccharides, effect of in vitro aging of fibroblasts

468

Pharmacology of systemic analgesics

469

Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells

470

Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals

471

Pharmacology of the human red cell voltage-dependent cation channel. Part II: inactivation and blocking

472

Pharmacology of the human red cell voltage-dependent cation channel: Part I. Activation by clotrimazole and analogues

473

Pharmacology of the low-molecular-weight heparins, ,

474

Pharmacology of vascular smooth muscle: C.J. Garland and J.A. Angus (Editors) Oxford University Press, Oxford, UK, 1996; stg£65.00; 435 pp.; ISBN 0-19-262387-7

475

Pharmacology Teaching Methods and Affective Factors in Their Success in Educating Undergraduate Medical Students: A Scoping Review

476

Pharmacology, taxonomy and phytochemistry of the genus Artemisia specifically from Pakistan: a comprehensive review

477

Pharmacomechanical Thrombolytic Treatment in Symptomatic Acute and Subacute Deep Vein Thrombosis

478

Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents Original Research Article

479

Pharmacophagous feeding stimulant activity of neo-clerodane diterpenoids for the turnip sawfly, Athalia rosae ruficornis

480

Pharmacophore and QSAR Modeling of Endothelial Nitric Oxide Synthase Inhibitors and Subsequent Validation and In Silico Search for New Hits

481

Pharmacophore and structure–activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase Original Research Article

482

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors

483

Pharmacophore identification and 3D-QSAR studies in N-(2-benzoyl phenyl)-l-tyrosines as PPARγ agonists Original Research Article

484

Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr5,12, Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection Original Research Article

485

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

486

Pharmacophore identification of KSP inhibitors

487

Pharmacophore identification of Raf-1 kinase inhibitors

488

Pharmacophore identification of α1A-adrenoceptor antagonists

489

Pharmacophore interactions analysis and prediction of inhibitory activity of 1,7-diazacarbazoles as checkpoint kinase 1 inhibitors: application of molecular docking, 3D-QSAR and RBF neural network

490

Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors

491

Pharmacophore mapping studies on indolizine derivatives as 15-LOX inhibitors

492

Pharmacophore mapping studies on pyrazoles as anti-proliferative agents

493

Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones

494

Pharmacophore modeling and atom-based 3D-QSAR studies on amino derivatives of indole as potent isoprenylcysteine carboxyl methyltransferase (Icmt) inhibitors

495

Pharmacophore modeling and in silico screening for new KDR kinase inhibitors

496

Pharmacophore modeling and molecular dynamics simulation to identify the critical chemical features against human sirtuin 2 inhibitors

497

Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors

498

Pharmacophore modeling of cytochromes P450

499

Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) Original Research Article

500

Pharmacophore Modeling, Virtual Screening, Molecular Docking, DFT, and ADMET Analyses to Develop Newer generation Dual Orexin Receptor Antagonist Targeting Insomnia

501

Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as α1-adrenoceptor antagonists

502

Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel class of monoamine transporter inhibitors

503

Pharmacophore-based discovery of ligands for drug transporters

504

Pharmacophore-Based discovery of substituted pyridines as novel dopamine transporter inhibitors

505

Pharmacophore-Based discovery, synthesis, and biological evaluation of 4-phenyl-1-arylalkyl piperidines as dopamine transporter inhibitors

506

Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel

507

Pharmacophore-based virtual screening: The discovery of novel methionyl-tRNA synthetase inhibitors

508

Pharmacophoric features and Ca2+ ion holding capacity of verapamil

509

Pharmacophoric features of nucleosidic HIV-1RT inhibitors Original Research Article

510

Pharmacophoric features of Pseudomonas aeruginosa deacetylase LpxC inhibitors: An electronic and structural analysis

511

Pharmacophotonics: Utilizing multi-photon microscopy to quantify drug delivery and intracellular trafficking in the kidney

512

Pharmacopoeia of culture media — additional monographs (IV)

513

Pharmacopoeia of culture media—additional monographs (III)

514

Pharmacopoeial quality of drugs supplied by Nigerian pharmacies

515

Pharmacopuncture Versus Acepromazine in Stress Responses of Horses During Road Transport

516

Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics

517

Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis

518

Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009

519

Pharmacotherapy and evolution

520

Pharmacotherapy and smoking cessation at a tobacco dependence clinic

521

Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development

522

Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review

523

Pharmacotherapy for obesity

524

Pharmacotherapy for pre diabetes: moving ahead

525

Pharmacotherapy for pregnant women with addictions

526

Pharmacotherapy for Reducing the Grieving Process of Romantic Relationship Breakup: A Clinical Trial

527

Pharmacotherapy for regional musculoskeletal pain

528

Pharmacotherapy for Retinoblastoma

529

Pharmacotherapy for severe aggression in a child with autism: “open label” evaluation of multiple medications on response frequency and intensity of behavioral intervention

530

Pharmacotherapy in acute coronary syndromes and acute myocardial infarction

531

Pharmacotherapy In Cardiopulmonary Resuscitation (CPR)

532

Pharmacotherapy in Endocrinology: Diabetes, Obesity, and Hy-perlipidemia- Review Article

533

Pharmacotherapy in percutaneous coronary intervention

534

Pharmacotherapy in the extreme longevity

535

Pharmacotherapy of bulimia nervosa and binge eating disorder

536

Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding

537

Pharmacotherapy of Depressed Children and Adolescents: Current Issues and Potential Directions

538

Pharmacotherapy of first-episode schizophrenia

539

Pharmacotherapy of impulsive aggression: A quality comparison of controlled studies

540

Pharmacotherapy of inflammatory process by ginger extract (Zingiber officinale) ointment

541

Pharmacotherapy of obesity

542

Pharmacotherapy of obesity

543

Pharmacotherapy of Prograf (Tacrolimus) in Liver Transplant Recipients; Consideration of Itsי Levels with Efficacy and Toxicity

544

Pharmacotherapy of schizophrenia

545

Pharmacotherapy of schizophrenia

546

Pharmacotherapy of schizophrenia

547

Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches

548

Pharmacotherapy of social anxiety disorder

549

Pharmacotherapy of somatoform disorders

550

Pharmacotherapy or Psychotherapy? Selective Treatment Depression in The Infertile Women with Recurrent Pregnancy Loss: A Triple-Arm Randomized Controlled Trial

551

Pharmacotherapy Plays Main Role in Managing Acute Epiploic Appendagitis: A Case Report

552

Pharmacotherapy to Improve the Acquired Aphasia following Brain Damages: A Review Study

553

Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (r-TPA) in Acute Ischemic Stroke

554

Pharmaco-toxicological study of diterpenoids Original Research Article

555

Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)

556

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis

557

Pharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements

558

Pharmacovigilance in Qatar: a survey of pharmacists

559

Pharmacovigilance into 2000

560

PHARMACOVIGILANCE, 2nd Edition. R. Mann and E. Andrews, editors. Chichester:John Wiley & Sons; 2007.

561

Pharmacy and herbal medicine in the US

562

Pharmacy and Pharmacology Research in the BRICS Countries: A Scientometric Analysis

563

Pharmacy and the US Health Care System

564

Pharmacy approach to a case of acute diarrhoea with dehydration in Antalya, Turkey

565

Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions

566

Pharmacy education instruction: Preference and practices, Saudi students’ perception

567

Pharmacy impact on medication reconciliation in the medical intensive care unit

568

Pharmacy information systems in Tehran university hospitals and their relationship with pharmaceutical companies

569

Pharmacy madness

570

Pharmacy or PharmaNBIC: Thinking about 50 years ahead of pharmacy today

571

Pharmacy practice research: challenges and opportunities

572

Pharmacy practice, 3rd edition: Patricia Stone, Stephen J Curtis; Pharmaceutical Press, London, August 2002, 344pp, price £29.95 paperback, ISBN 0 85369 482 6,

573

Pharmacy Students Motivation, Preparation and Factors Affecting Pursuing Postgraduate Education in Ethiopian University

574

Pharmacy Studentsʹʹ Self-Identified Interests in a Hospital Pharmacy Internship Course in Iran

575

Pharmacy Students’ Satisfaction Rate with their Majors and its Relationship with Educational Status in Kermanshah University of Medical Sciences (2014)

576

Pharmacy Students’ Satisfaction Rate with their Majors and its Relationship with Educational Status in Kermanshah University of Medical Sciences (2014)

577

PHARMACY TOXICOLOGICAL ANALYSES FOR POISONED PATIENTS AT A TEACHING HOSPITAL IN SAUDI ARABIA

578

Pharmacyʹs attempts to extend its roles: A case study in South Africa

579

Pharmaphilia and pharmaphobia

580

p-Harmonic functions with boundary data having jump discontinuities and Baernsteinʹs problem

581

PHARMSEARCH, the Pharmaceutical Patents database produced by INPI

582

PHAROS: A pluri-detector, high-resolution, analyser of radiometric properties of soil

583

PHAROS: A pluri-detector, high-resolution, analyser of radiometric properties of soil

584

PHAROS: a spectrometer-on-a-chip for digital radiology systems with spectral detection

585

PHAROS: a spectrometer-on-a-chip for digital radiology systems with spectral detection

586

PHA–rubber blends: Synthesis, characterization and biodegradation

587

Pharyngeal Airway: An Analysis Using 2D vs. 3D Images in Different Malocclusions

588

Pharyngeal Aspiration of Complete Upper Denture in 90-Year-Old Man; a Case Report

589

Pharyngeal dysphagia in postesophagectomy patients: correlation with deglutitive biomechanics

590

Pharyngeal Myiasis Caused by Sheep Botfly, Oestrus ovis (Diptera: Oestridae) Larva, Tabriz, East Azarbaijan Province, Iran: A Case Report

591

Pharyngeal Packing during Rhinoplasty: Advantages and Disadvantages

592

Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy

593

Pharyngeal sensation and gag reflex in healthy subjects

594

Pharyngeal thyroid: a case report

595

Pharyngitis followed by hypoxia and sepsis: Lemierre syndrome

596

Pharyngitis treatment by emergency physicians from 1995 to 2001: do our antibiotic choices conform to national guidelines?

597

Pharyngocolonic Anastomosis for Esophageal Reconstruction in Corrosive Esophageal Stricture

598

Pharyngo-Colostomy With Supraglottic Partial Laryngectomy in Caustic Oropharyngeal Stricture

599

Pharyngocutaneous Fistula after Laryngectomy: Incidence, Predisposing Factors, and Outcome

600

Pharyngocutaneous Fistula as a Rare Late Postoperative Complication Following Submandibulectomy: A Case Report

601

Pharyngo-enteral anastomosis for esophageal reconstruction in diffuse corrosive esophageal stricture

602

PHARYNGOESOPHAGEAL FOREIGN BODIES

603

Pharyngoesophageal pH monitoring

604

Pharyngolaryngeal Involvement by Varicella-Zoster Virus

605

Pharyngo-oesophageal Foreign Bodies: Implications for Health Care Services in Nigeria

606

Phase (Liquid/Solid) Dependence of the Normal Spectral Emissivity for Iron, Cobalt, and Nickel at Melting Points

607

Phase 1 Trial of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Decompensated Liver Cirrhosis

608

Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate

609

Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C

610

Phase accumulation model analysis of quantum well resonances formed in ultra-thin Ag, Au films on W(1 1 0)

611

Phase ac-sensitivity of oxidic and acetylacetonic gas sensors

612

PHASE ADVANCE AFTER ONE OR THREE SIMULATED DAWNS IN HUMANS

613

Phase Agility of Reflectarray Patch Element Using Nematic Liquid Crystal

614

PHASE ANALYSIS AND DENSIFICATION OF STEATITE-BASED CERAMICS

615

Phase analysis and dielectric properties of oxides obtained in the MgO–(1–x)Nb2O5–(x)Ta2O5 system

616

Phase analysis and focusing of synchrotron radiation

617

Phase analysis and focusing of synchrotron radiation

618

Phase analysis and microstructure evolution of a bone china body modified with scrap addition

619

Phase analysis and microwave dielectric properties of BaO–Nd2O3–5TiO2 composite ceramics using variable size TiO2 reagents

620

Phase analysis and microwave dielectric properties of LTCC TiO2 with glass system

621

Phase Analysis and Oxygen Storage Capacity of Ceria-Lanthana-Based TWC Promoters Prepared by Sol–Gel Routes

622

Phase analysis and wear behavior of in-situ spark plasma sintered Ti3SiC2

623

Phase analysis in delayed systems

624

Phase Analysis in the Solder Joint of Sn-Cu Solder/IMCs/Cu Substrate

625

Phase analysis of Cu(In1 − xGax)Se2 prepared by solvothermal method

626

Phase Analysis of Gated Myocardial Perfusion Single-Photon Emission Computed Tomography Compared With Tissue Doppler Imaging for the Assessment of Left Ventricular Dyssynchrony Original Research Article

627

Phase analysis of Gd5(SixGe1−x)4 alloys prepared from different purity Gd with x = 0.475 and 0.43 Original Research Article

628

Phase analysis of Gd5(SixGe1-x)4 alloys prepared from different purity Gd with x = 0.475 and 0.43

629

Phase analysis of Mg–La–Nd and Mg–La–Ce alloys

630

Phase analysis of superconducting polycrystalline MgB2

631

Phase analysis of surface layers irradiated with high-energy electron beam using Mِssbauer spectroscopy

632

Phase analysis of surface layers irradiated with high-energy electron beam using Mِssbauer spectroscopy

633

Phase analysis of TaN/Ta barrier layers in sub-micrometer trench structures for Cu interconnects

634

Phase and aggregation behaviour of alkylglycosides

635

Phase and aggregational studies of some inversely soluble aqueous formulations

636

Phase and amplitude control of optical bistability in the three-coupled quantum wells

637

Phase and amplitude of ecosystem carbon release and uptake potentials as derived from FLUXNET measurements

638

Phase and anti-phase synchronization of fractional order chaotic systems via active control

639

Phase and Correlation in `Randomʹ Seismic Fields and the Reconstruction of the Green Function

640

Phase and critical behavior in type III phase diagrams

641

Phase and electrical behaviour in the Bi14W1 − xLaxO24 − 3x/2 system

642

Phase and group synchronization in second-harmonic generation of ultrashort light pulses in one-dimensional photonic crystals

643

Phase and intensity control through diffractive optical elements in X-ray microscopy

644

Phase and microstructural evolution during the heat treatment of Sm–Ca–α-sialon ceramics

645

Phase and microstructural evolution of heat treated nanocrystalline powders in Al2O3-MgO binary system

646

Phase and microstructural evolution of Ir–Si binary alloys with fcc/silicide structure

647

Phase and microstructural evolution of yttrium-doped nanocrystalline alumina: A contribution of advanced microscopy techniques

648

Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings

649

Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings

650

Phase and microstructural stability of solution precursor plasma sprayed thermal barrier coatings

651

Phase and microstructure evolution during hydrothermal solidification of clay–quartz mixture with marble dust source of reactive lime

652

Phase and microstructure evolution during the synthesis of WC nanopowders via thermal processing of the precursor

653

Phase and microstructure evolution in precursor plasma-sprayed YIG coatings

654

Phase and microstructure formation and their influence on the strength of two types of glass-ceramics

655

Phase and microstructure of TbCu7-type SmFe melt-spun powders

656

Phase and microstructure of tungsten coating on C/C composite prepared by double-glow plasma

657

Phase and microstructure stabilities of LiAlO2 in molten Li/Na carbonate for molten carbonate fuel cells

658

Phase and morphological transformations of GaS single crystal surface by thermal treatment

659

Phase and morphology changes induced by acid treatment following alkaline reaction of mesoporous anatase: Effect of anions

660

Phase and morphology control of LTA/FAU zeolites by adding trace amounts of inorganic ions

661

Phase and morphology dependence on the annealing temperature of tin sulfides and oxides prepared by thermal decomposition of organotin precursors

662

Phase and morphology evolution of bismuth ferrites via hydrothermal reaction route

663

Phase and morphology evolution study of ball milled Mg–Co hydrogen storage alloys

664

Phase and morphology investigation of BaxSr1−xTiO3 (x = 0.6, 0.7 and 0.8) powders

665

Phase and morphology investigation of BaxSr1−xTiO3 (x = 0.6, 0.7 and 0.8) powders

666

Phase and orientational ordering of A–B–A tri-block co-polymers guest in a quenched host of low molecular weight rod molecules

667

Phase and reaction equilibria of acetic acid–1-pentanol–water– n-amyl acetate system at 760 mm Hg

668

Phase and reaction equilibria of the acetic acid-isopropanol-isopropyl acetate-water system at 760 mmHg

669

Phase and rheological behaviors of xanthan/amylose and xanthan/starch mixed systems

670

Phase and scaling properties of determinants arising in topological field theories

671

Phase and sedimentation behavior of oil (octane) dispersions in the presence of model mineral aggregates

672

Phase and shape controlling of MnS nanocrystals in the solvothermal process

673

Phase- and shape-controlled hydrothermal synthesis of CdS nanoparticles, and oriented attachment growth of its hierarchical architectures

674

Phase- and shape-controlled synthesis of cadmium hydroxyl chloride microstructures via an ammonia-assisted conversion of 1D CdQCl (Q=quinoline) complex microwires Original Research Article

675

Phase and size control of nanometer-size materials synthesized in supersonic jet expansions

676

Phase and size control of nanometer-size materials synthesized in supersonic jet expansions

677

Phase and size separations occurring during the injection of model pastes composed of β-tricalcium phosphate powder, glass beads and aqueous solutions

678

Phase and space resolved optical emission spectroscopic investigations of an inductively coupled RF plasma using an imaging acousto-optic spectrometer

679

Phase and spectral properties of optically injected semiconductor lasers

680

Phase and state transition effects on dielectric, mechanical, and thermal properties of polyols

681

Phase and structural behavior of SmAlO3–RAlO3 (R = Eu, Gd) systems

682

Phase and structural change of carbonized wood materials by hydrothermal treatment

683

Phase and structural changes of Nd12Fe82B6 alloy during mechanical milling in both an argon and a hydrogen atmosphere

684

Phase and structural characterization of Sr2Nb2O7 and SrNbO3 thin films grown via pulsed laser ablation in O2 or N2 atmospheres

685

Phase and Structural Modifications in Porous Silicon Under Pulse Heating

686

Phase and structural transformations in magnetorheological suspensions

687

Phase and structure transformations in the titanium interlayer during the nickel silicidation on Si(1 0 0) substrate

688

Phase and Surface Properties of Lipid Bilayers Containing Neoglycolipids

689

Phase and texture analysis of a hydride blister in a Zr–2.5%Nb tube by synchrotron X-ray diffraction Original Research Article

690

Phase and thermal stability of nanocrystalline hydroxyapatite prepared via microwave heating

691

Phase and valence transitions in Ba2LnSnxNb1−xO6−δ

692

Phase and valence transitions in Ba2LnSnxSb1−xO6−δ (Ln=Pr and Tb)

693

Phase and velocity distributions in vertically upward high-viscosity two-phase flow

694

Phase and viscosity behaviour of refrigerant–lubricant mixtures

695

Phase and volumetric behavior of binary systems containing carbon dioxide and lubricants for transcritical refrigeration cycles

696

Phase and volumetric behaviour of mixtures of carbon dioxide (R-744) and synthetic lubricant oils

697

Phase angle dependence of sand density observable in hyperspectral reflectance

698

Phase angle in the Cu/polyimide/alumina system

699

Phase angle in the Cu/polyimide/alumina system

700

Phase Angle Measurement in Healthy Human Subjects through Bio-Impedance Analysis

701

Phase angle spectrum analysis and body water

702

Phase approximation by logarithmic sampling of gain

703

Phase assemblages of (Ca,Mg)-α-sialon ceramics derived from an α-sialon powder prepared by SHS

704

Phase assembly and microstructure of CeO2-doped ZrO2 ceramics prepared by spark plasma sintering

705

Phase association of polycyclic aromatic hydrocarbons in the Minjiang River Estuary, China

706

Phase associations and lipid distributions in the seasonally ice-covered Arctic estuary of the Mackenzie Shelf

707

Phase associations and potential selective extraction methods for selected high-tech metals from ferromanganese nodules and crusts with siderophores

708

Phase associations of barium in marine sediments

709

Phase Asymptotic Semiflows, Poincaréʹs Condition, and the Existence of Stable Limit Cycles

710

Phase asynchrony between coronal index and sunspot numbers Original Research Article

711

Phase attraction in sensorimotor synchronization with auditory sequences: Effects of Tsingle and periodic distractors on synchronization accuracy.

712

Phase averaging of the coherent head-on beam–beam instability

713

Phase averaging of the coherent head-on beam–beam instability

714

Phase averaging of the precessing vortex core in a swirl burner under piloted and premixed combustion conditions

715

Phase balancing using mixed-integer programming [distribution feeders]

716

Phase balancing using simulated annealing

717

Phase barograms–phase diagrams of vapor pressure: Eutectoid phase formation in binary systems

718

Phase based feature detector consistent with human visual system characteristics

719

720

Phase behavior and a modified Kwei equation for ternary polymer blends containing stereoregular PMMA

721

Phase behavior and characterization of ionic liquids based microemulsions

722

Phase behavior and compressibility factor of two China gas condensate samples at pressures up to 95 MPa

723

Phase behavior and crystal structure of 3-(1-naphthyloxy)- and 3-(4-indolyloxy)-propane-1,2-diol, synthetic precursors of chiral drugs propranolol and pindolol

724

Phase Behavior and Crystal Structure of Perovskite-Type Rare Earth Complex Oxides

725

Phase behavior and crystallization in blends of a low molecular weight polyethylene-block-poly(ethylene oxide) diblock copolymer and poly(hydroxyether of bisphenol A)

726

Phase behavior and emulsion formation of novel fluoroether amphiphiles in carbon dioxide

727

Phase behavior and extraction characteristics of polycyclic aromatic hydrocarbon mixtures with hexane in sub- and supercritical state

728

Phase behavior and hydrogen bonding in biomembrane mimicing polyurethanes with long side chain fluorinated alkyl phosphatidylcholine polar head groups attached to hard block

729

Phase behavior and interfacial curvature in water-oil-surfactant systems

730

Phase behavior and its viscoelastic response of polylactide/poly(ε-caprolactone) blend

731

Phase behavior and kinetics of a new bond-order potential for silicon

732

Phase behavior and Lα-phase of a new catanionic system formed by cationic hydrocarbon and anionic fluorocarbon surfactants

733

Phase behavior and mechanism of membrane formation for polyimide/DMSO/water system

734

Phase behavior and mesoscale solubilization in aqueous solutions of hydrotropes

735

Phase behavior and microstructural length scales of a diblock copolymer in the presence of a selective solvent

736

Phase behavior and microstructure of preheated soy proteins and κ-carrageenan mixtures

737

Phase behavior and microstructures of the Gemini (12-3-12,2Br−)–SDS–H2O ternary

738

Phase behavior and miscibility in blends of poly(sebacic anhydride)/poly(ethylene glycol)

739

Phase behavior and mixed ionic–electronic conductivity of Ba4Sb2O9

740

Phase behavior and modeling of the poly(methyl methacrylate)–CO2–methyl methacrylate system

741

Phase behavior and modeling of the systems CO2-acetonitrile and CO2-acrylic acid

742

Phase behavior and molecular chain environment of organic–inorganic hybrid materials based on poly(n-butyl methacrylate-co-(3-(methacryloxypropyl)) trimethoxysilane)

743

Phase behavior and morphology of poly(phenylene ether)/epoxy blends

744

Phase behavior and optical- and mechanical properties of the binary system isotactic polypropylene and the nucleating/clarifying agent 1,2,3-trideoxy-4,6:5,7-bis-O-[(4-propylphenyl) methylene]-nonitol

745

Phase behavior and optical investigation of two synthetic luminol derivatives and glycolipid mixed monolayers at the air–water interface

746

Phase behavior and phase structure of 1:1 salt-free catanionic surfactant dodecyltrimethylammonium decanoate

747

Phase behavior and physical properties of petroleum reservoir fluids from acoustic measurements

748

Phase behavior and process parameters effects on the characteristics of precipitated theophylline using carbon dioxide as antisolvent

749

PHASE BEHAVIOR AND PROPERTIES OF POLYURETHANE-PVC BLENDS AND FIBERS

750

PHASE BEHAVIOR AND PROPERTIES OF POLYURETHANE-PVC BLENDS AND FIBERS

751

Phase behavior and protein partitioning in aqueous two-phase systems of cationic–anionic surfactant mixtures

752

Phase behavior and reaction of polyethylene in supercritical water at pressures up to 2.6 GPa and temperatures up to 670°C

753

Phase behavior and rheology in water and in model paint formulations thickened with HM-EHEC: influence of the chemical structure and the distribution of hydrophobic tails

754

Phase behavior and SANS investigations of edible sugar–limonene microemulsions

755

Phase behavior and size variation of AOT-based W/O microemulsions by substituting H+ for Na+ as the counterion

756

Phase behavior and size variation of Na-AOT-based W/O microemulsions by increasing NaOH concentration in the water pool

757

Phase behavior and spherical hollow particle formation by dipeptide-based two-headed amphiphiles in a mixed solvent of dimethyl sulfoxide and water

758

Phase behavior and structure formation for diblock copolymers composed of side-chain liquid crystalline and glassy amorphous components

759

Phase behavior and surface tensions of amphiphilic fluorinated random copolymer aqueous solutions

760

Phase behavior and thermodynamic properties in the system Fe–Al

761

Phase behavior and thermodynamic properties in the system Fe–Al

762

Phase behavior and vapor pressures of the pyrene + 9,10-dibromoanthracene system

763

Phase behavior and viscous properties of cetyltrimethylammonium bromide and sodium dodecyl sulfonate aqueous mixtures

764

Phase behavior and water vapor transport in BIONOLLE/polymethylmethacrylate blends

765

Phase behavior applications of SAFT based equations of state—from associating fluids to polydisperse, polar copolymers

766

Phase behavior at low temperature of poly(tetrafluoroethylene) by temperature-modulated calorimetry

767

Phase behavior for carbon dioxide + ethanol system: Experimental measurements and modeling with a cubic equation of state

768

Phase behavior for carbon dioxide/tetraalkoxysilane systems

769

Phase behavior for the [Bmim]BF4 aqueous two-phase systems containing ammonium sulfate/sodium carbonate salts at different temperatures: Experimental and correlation

770

Phase behavior for the poly(dimethylsiloxane) in supercritical fluid solvents

771

Phase behavior for the poly[2-(2-ethoxyethoxy)ethyl acrylate] and 2-(2-ethoxyethoxy)ethyl acrylate in supercritical solvents

772

Phase behavior for the supercritical ethylene + hexane + polyethylene systems

773

Phase behavior in liquid crystallization for diblock copolymers consisting of rubbery amorphous and side-chain liquid crystalline components

774

Phase behavior in mixtures of cationic surfactant and anionic polyelectrolytes

775

Phase behavior in the system LaxSr1-xMnO(5+x)/2 (x=0.8-1.0) with trivalent state of manganese ion

776

Phase behavior measurement for poly(isobornyl acrylate) + cosolvent systems in supercritical solvents at high pressure

777

Phase behavior measurement for the system CO2 + glycerol + ethanol at high pressures

778

Phase behavior measurement of the binary carbon dioxide–N,N-dimethylacetamide and carbon dioxide–N,N-diethylacetamide systems at high pressure

779

Phase behavior measurement on the binary mixture for isopropyl acrylate and isopropyl methacrylate in supercritical CO2

780

Phase behavior of (polyacrylamides + water) solutions: concentration, pressure and isotope effects

781

Phase behavior of 1,3,5-tri-tert-butylbenzene–carbon dioxide binary system

782

Phase behavior of a model surfactant–solvent system at intermediate and high densities

783

Phase behavior of a near-critical reservoir fluid mixture

784

Phase behavior of a nematic liquid crystal in polybutadiene networks

785

Phase behavior of a simple model of ferrocolloidal fluid

786

Phase behavior of a ternary system of poly[p-perfluorooctyl-ethylene(oxy, thio, sulfonyl)methyl styrene] and poly[p-decyl(oxy, thio, sulfonyl)methyl styrene] in supercritical solvents

787

Phase behavior of a two-dimensional quenched–annealed lattice gas with nearest-neighbor attraction. Grand canonical Monte Carlo simulation

788

Phase behavior of amphiphile–solvent systems from lattice Monte Carlo simulations

789

Phase behavior of an amphiphilic molecule in the presence of two solvents by dissipative particle dynamics

790

Phase behavior of aqueous two-phase systems composed of 1-alkyl-3-methylimidazolium bromide + Rb2CO3/Cs2CO3 + water

791

Phase behavior of aqueous two-phase systems composed of 1-ethyl-3-methylimidazolium tetrafluoroborate and phosphate-based salts at different temperatures

792

Phase behavior of Athabasca bitumen + water mixtures at high temperature and pressure

793

Phase behavior of banana-shaped molecules under pressure

794

Phase Behavior of Binary and Ternary Mixtures of Poly(decyl acrylate)-Supercritical Solvents-Decyl Acrylate and Poly(decyl methacrylate)-CO2-Decyl Methacrylate Systems

795

Phase behavior of binary mixture for the isoalkyl acetate in supercritical carbon dioxide

796

Phase behavior of binary mixture of asphaltene + solvent and ternary mixture of asphaltene + solvent + precipitant

797

Phase behavior of binary mixtures of thick and thin hard rods

798

Phase Behavior of Binary Stockmayer and Polarizable Lennard-Jones Fluid Mixtures Using Adiabatic Nuclear and Electronic Sampling

799

Phase behavior of biodegradable amphiphilic poly(l,l-lactide)-b-poly(ethylene glycol)-b-poly(l,l-lactide)

800

Phase behavior of blends of high temperature copolycarbonates with styrene/acrylonitrile copolymers

801

Phase behavior of blends of linear and branched polyethylenes on micron length scales via ultra-small angle neutron scattering (USANS)

802

Phase behavior of blends of linear low density polyethylene and poly(ethene-propene-1-butene)

803

Phase behavior of blends of poly(2,6-dimethyl-1,4-phenylene oxide)/polystyrene/poly(o-chlorostyrene-co-p-chlorostyrene) copolymer

804

PHASE BEHAVIOR OF BROMINATED POLY(ISOBUTYLENE-co-4-METHYLSTYRENE)/ GENERAL PURPOSE RUBBER BLENDS

805

PHASE BEHAVIOR OF BROMINATED POLY(ISOBUTYLENE-co-4-METHYLSTYRENE)/ GENERAL PURPOSE RUBBER BLENDS

806

Phase behavior of carbon dioxide mixtures with n-alkanes and n-perfluoroalkanes

807

Phase behavior of carbon dioxide + medroxyprogesterone acetate system at high pressures

808

Phase behavior of carbon dioxide—low-molecular weight triglycerides binary systems: measurements and thermodynamic modeling

809

Phase behavior of castor oil in compressed propane and n-butane

810

Phase behavior of catalytic deactivated compounds and water with 1-ethyl-3-methylimidazolium acetate [EMIM][OAc] ionic liquid at T = 298.15–323.15 K and p = 1 bar

811

Phase behavior of CO2 + polyethylene glycol + ethanol at pressures up to 20 MPa

812

Phase behavior of concentrated hydroxypropyl methylcellulose solution in the presence of mono and divalent salt

813

Phase behavior of crosslinked polyisoprene rubber and supercritical carbon dioxide

814

Phase behavior of didecylpyrrolidium bromide in aqueous solution

815

Phase behavior of diisobutyl adipate–carbon dioxide mixtures

816

Phase behavior of dipalmitoylphosphatidylethanolamine in dimethylsulfoxide–water mixture

817

Phase behavior of DNA in the presence of cetyltrimethylammonium bromide \ alkyl polyglucoside surfactant mixture

818

Phase behavior of DNA solutions in the presence of salts

819

Phase behavior of imidazolium and phosphonium tetrafluoroborates with dihydroxy alcohols

820

Phase Behavior of Ionic Liquid-LiX Mixtures: Pyrrolidinium Cations and TFSI- Anions

821

Phase behavior of iridescent phases with calcium dodecyl sulfate, octanol or decanol, and water, and the effect of the presence of sodium ions

822

Phase behavior of isotactic polypropylene/C4-solvents at high pressure. Experimental data and SAFT modeling

823

Phase behavior of lemon and bergamot peel oils in supercritical CO2

824

Phase behavior of Lennard-Jones fluids in pores formed between two cylindrical walls

825

Phase behavior of LiClO4-doped poly(ε-caprolactone)-b-poly(ethylene oxide) hybrids in the presence of competitive interactions

826

Phase behavior of linear polystyrene-block-poly(2-vinylpyridine)-block-poly(tert-butyl methacrylate) triblock terpolymers

827

Phase behavior of liquid-crystalline copolymer/liquid crystal blends

828

Phase behavior of magnetic nanoparticles dispersions in bulk and confined geometries

829

Phase behavior of metals at very high P–T conditions: A review of recent experimental studies Original Research Article

830

Phase behavior of methane and carbon dioxide hydrates in meso- and macro-sized porous media

831

Phase behavior of microemulsions based on food-grade nonionic surfactants: effect of polyols and short-chain alcohols

832

Phase behavior of mixtures of ionic liquids and organic solvents

833

Phase behavior of n-hexadecyl phosphate in Gibbs adsorption layers

834

Phase behavior of ovalbumin and carboxymethylcellulose composite system

835

Phase behavior of phytosterols and cholesterol in carbon dioxide-expanded ethanol

836

Phase behavior of poly(1,1-dihydroperfluorooctylacrylate) in supercritical carbon dioxide

837

Phase behavior of poly(3-alkylthiophene)/polystyrene blends

838

Phase behavior of poly(dimethylsiloxane)–poly(ethylene oxide) amphiphilic block and graft copolymers in compressed carbon dioxide

839

Phase behavior of poly(ether imide) in mixtures of N-methyl-2-pyrrolidinone and methylene chloride

840

Phase behavior of poly(N-isopropylacrylamide) in binary aqueous solutions

841

Phase behavior of poly(N-isopropylacrylamide) in water–methanol cononsolvent mixtures and its relevance to membrane formation

842

Phase behavior of polyaniline/dodecyl benzene sulphonic acid mixture

843

Phase behavior of polyetherimide/benzophenone/triethylene glycol ternary system and its application for the preparation of microporous membranes

844

Phase behavior of polymer/diluent/diluent mixtures and their application to control microporous membrane structure

845

Phase behavior of polymer–diluent systems characterized by temperature modulated differential scanning calorimetry

846

Phase behavior of polymers containing ether groups in carbon dioxide

847

Phase behavior of polymer–solvent mixtures

848

Phase behavior of polypropylene + n-pentane and polypropylene + n-pentane + carbon dioxide: modeling with cubic and non-cubic equations of state

849

Phase behavior of propane and n-pentane aerosol particles under conditions relevant to Titan

850

Phase behavior of random and ABC triblock methacrylic polyampholytes with poly(vinyl alcohol) in water: effect of pH and salt

851

Phase behavior of reservoir fluids: Comparisons of PC-SAFT and cubic EOS simulations

852

Phase Behavior of Rigid Objects on a Cubic Lattice

853

Phase behavior of Safaniya vacuum residue

854

Phase behavior of selected artificial lipids

855

Phase behavior of semicrystalline polymer blends

856

Phase behavior of serpentine mineral by carbothermal reduction nitridation

857

Phase Behavior of Sick House Syndrome(SHS) Chemicals

858

Phase behavior of siloxane-based amphiphiles in supercritical carbon dioxide

859

Phase behavior of some mono-substituted ferrocene- and [3]ferrocenophane-containing nematics with the cyclohexane ring in the rigid core

860

Phase behavior of sour natural gas systems using classical and statistical thermodynamic equations of states

861

Phase behavior of soybean oil, castor oil and their fatty acid ethyl esters in carbon dioxide at high pressures

862

Phase behavior of sunflower oil and soybean oil in propane and sulphur hexafluoride

863

Phase behavior of supercritical CO2/Styrene/Poly(ethylene terephthlate) (PET) system and preparation of polystyrene/PET composites

864

Phase behavior of ternary mannosylerythritol lipid/water/oil systems

865

Phase Behavior of the Binary and Ternary Mixtures of Biodegradable Poly((epsilon)-caprolactone) in Supercritical Fluids

866

Phase behavior of the binary refrigerant mixture chlorodifluoro-ethane (R22)-1,1,1,2-tetrafluoro-ethane (R134a): experimental investigation and theoretical modelling using the perturbed-anisotropic-chain theory (PACT)

867

Phase behavior of the binary system ethane+linalool

868

Phase behavior of the binary system near-critical dimethylether and tripalmitin: measurements and thermodynamic modeling

869

Phase behavior of the monoolein–water system: The effects of addition of the hydrocarbon 1,8-cineole and supercritical carbon dioxide

870

Phase behavior of the orange essential oil/sodium bis(2-ethylhexyl)sulfosuccinate/water system

871

Phase behavior of the poly(neopentyl methacrylate) + supercritical fluid solvents + neopentyl methacrylate system and CO2 + neopentyl methacrylate mixtures at high pressure

872

Phase behavior of the poly(vinyl pyrrolidone) + N-vinyl-2-pyrrolidone + carbon dioxide system

873

Phase behavior of the poly(vinyl pyrrolidone) + dichloromethane + supercritical carbon dioxide system

874

Phase behavior of the system hyperbranched polyglycerol + methanol + carbon dioxide

875

Phase behavior of the system lecithin–water: The effects of addition of the hydrocarbon 1,8-cineole and supercritical carbon dioxide

876

Phase behavior of the ternary 1-hexyl-3-methylimidazolium tetrafluoroborate + carbon dioxide + methanol system

877

Phase behavior of the ternary aqueous mixtures of two polydisperse ethoxylated nonionic surfactants

878

Phase behavior of the vanillin–CO2 system at high pressures

879

Phase behavior of tri-block copolymers in solution: Mesoscopic simulation study

880

Phase behavior of tricyanomethanide-based ionic liquids with alcohols and hydrocarbons

881

Phase behavior of two-component membranes

882

Phase behavior of unsymmetrical dimers on a square lattice

883

Phase behavior of vinyl fluoride in room-temperature ionic liquids [emim][Tf2N], [bmim][N(CN)2], [bmpy][BF4], [bmim][HFPS] and [omim][TFES]

884

Phase behavior of water + hydrocarbon binary systems by using multi-fluid nonrandom lattice hydrogen bonding theory

885

Phase behavior of water-in-supercritical carbon dioxide microemulsion with sodium salt of bis(2,2,3,3,4,4,5,5-octafluoro-1-pentanol) sulfosuccinate

886

Phase behavior of xenon hydrate system

887

Phase behavior of β-d galactose pentaacetate–carbon dioxide binary system

888

Phase behavior on the poly[octyl (meth)acrylate] + supercritical fluid solvents + monomer and CO2 + monomer mixtures at high pressure

889

Phase behavior prediction of complex petroleum fluids

890

Phase behavior prediction of petroleum fluids with minimum characterization data

891

Phase behavior studies of a perfluoropolyether in high-pressure carbon dioxide

892

Phase behavior studies of a perfluoropolyether in high-pressure carbon dioxide

893

Phase behavior study of amphiphilic drugs: Effect of pharmaceutical excipients

894

Phase behavior study of paclitaxel loaded amphiphilic copolymer in two solvents by dissipative particle dynamics simulations

895

Phase behavior study of PEB/PES blend by time resolved laser light scattering

896

Phase behavior, formation, and rheology of cubic and hexagonal phase based gel emulsions in water/tetraglyceryl lauryl ether/oil systems

897

Phase behavior, microstructure transition, and antiradical activity of sucrose laurate/propylene glycol/the essential oil of Melaleuca alternifolia/water microemulsions

898

Phase behavior, morphology and interfacial structure in thermoset/thermoplastic elastomer blends of poly(propylene glycol)-type epoxy resin and polystyrene–b-polybutadiene

899

Phase behavior, nucleation and optical properties of the binary system isotactic polypropylene/N,N′,N″-tris-isopentyl-1,3,5-benzene-tricarboxamide

900

Phase behavior, ordering and self-assembly in monolayers

901

Phase behavior, photopolymerization, and morphology development in mixtures of eutectic nematic liquid crystal and photocurable monomer

902

Phase behavior, polymorphism and spherulite morphology in Poly(1,4-butylene adipate) interacting with two structurally similar acrylic polymers

903

Phase Behavior, Thermal Stability and Rheological Properties of PPEK/PC Blends

904

Phase behaviors and light scattering for dilute mixtures of C12E5 and lauric acid

905

Phase behaviors for the supercritical ethylene + 1-hexene + hexane + polyethylene systems at elevated temperatures and pressures

906

Phase behaviors of ammonia/R-125 mixtures

907

Phase behaviors of bidisperse nanoparticle/block copolymer mixtures in dilute solutions

908

Phase Behaviors of Binary Hard-Sphere Mixtures Using Simple Analytical Equations of State

909

Phase behaviors of comb-like liquid crystalline polysiloxanes containing fluorinated mesogenic units

910

Phase behaviors of Gemini cationic surfactants/n-butanol/water systems

911

Phase behaviors of polymer solution confined between two concentric cylinders

912

Phase behaviors of smectic-A liquid crystal/linear polymer systems Original Research Article

913

Phase behaviors of solid polymer electrolyte/salt systems in lithium secondary battery: the ionic interaction and nonrandomness effect

914

Phase behaviors of solid polymer electrolytes/salt system in lithium secondary battery by group-contribution method: The pressure effect

915

Phase behaviors of sphere-forming triblock copolymers confined in nanopores: A dynamic density functional theory study

916

Phase behaviour and density of (methane+n-butane)

917

Phase behaviour and density of model reservoir fluids at high temperature and pressure

918

Phase behaviour and in vitro hydrolysis of wheat starch in mixture with whey protein

919

Phase behaviour and miscibility window in UCST-type blends of poly(styrene-co-acrylonitrile) and tetramethylbisphenol A oligosulfones

920

Phase behaviour and non-periodic crystallisation of random aromatic copolyesters and their side chain bearing systems

921

Phase behaviour and physico-chemical properties of the binary systems {1-ethyl-3-methylimidazolium thiocyanate, or 1-ethyl-3-methylimidazolium tosylate + water, or + an alcohol}

922

Phase behaviour and thermodynamics of poly(1,4-phenylene ether sulphone) and poly(ethylene oxide)/alkali-metal salt complex blends: a thermal analysis study

923

Phase behaviour in the vicinity of the three-phase solid–liquid–vapour line in asymmetric nonpolar systems at high pressures

924

Phase behaviour of 1-butyl-1-methylpyrrolidinium thiocyanate ionic liquid

925

Phase behaviour of 1-hexyloxymethyl-3-methyl-imidazolium and 1,3-dihexyloxymethyl-imidazolium based ionic liquids with alcohols, water, ketones and hydrocarbons: The effect of cation and anion on solubility

926

Phase behaviour of 1-methyl-3-octylimidazolium bis[trifluoromethylsulfonyl]imide with thiophene and aliphatic hydrocarbons: The influence of n-alkane chain length

927

Phase behaviour of a liquid crystalline polyetherester derived from 4′-hydroxy-1,1′-biphenyl-4-carboxylic acid and the ether-diol 4-(3-hydroxypropoxy)butan-1-ol

928

Phase behaviour of a mixed ionic/nonionic surfactant system used to prepare stable oil-in-water paraffin emulsions

929

Phase behaviour of a non-ionic surfactant–polymeric solution–water system during the phase inversion process

930

Phase behaviour of binary fluid mixtures: a global phase diagram solely in terms of pure component properties

931

Phase behaviour of binary mixtures of colloidal charged spheres

932

Phase behaviour of binary mixtures of LC compounds of different molecular structure and comparable molecular length: I. 4-(4′-Substituted phenylazo)phenyl-4″-alkoxybenzoates and 4-(4′-substituted phenyl carbonyloxy)phenyl-4″-alkoxybenzoates

933

Phase behaviour of dipalmitoylphosphatidylcholine/surfactant/water systems studied by infrared spectroscopy

934

Phase behaviour of gas hydrates of carbon dioxide in the presence of tetrahydropyran, cyclobutanone, cyclohexane and methylcyclohexane

935

Phase behaviour of gelatin/polydextrose mixtures at high levels of solids

936

Phase behaviour of globular protein and flexible polymer in an aqueous medium

937

Phase behaviour of heteronuclear dimers adsorbed on square and triangular lattices—a Monte Carlo study

938

Phase behaviour of high molecular mass methyl esters in supercritical ethane

939

Phase behaviour of high molecular weight oat β-glucan/whey protein isolate binary mixtures

940

Phase behaviour of hyperbranched polyesters and polyethers with modified terminal OH groups in supercritical solvents

941

Phase behaviour of ionic liquid 1-butyl-1-methylpyrrolidinium tris(pentafluoroethyl)trifluorophosphate with alcohols, water and aromatic hydrocarbons

942

Phase behaviour of lipid–cholesterol membranes

943

Phase behaviour of l-lactic acid based polymers of low molecular weight in supercritical carbon dioxide at high pressures

944

Phase behaviour of l-lactide in supercritical carbon dioxide at high pressures

945

Phase behaviour of Maya crude oil based on calorimetry and rheometry

946

Phase behaviour of microemulsions stabilised by double chain cationic surfactants and alcohol co-surfactants

947

Phase behaviour of mixtures containing antibiotics: Effect of hydrogen bonding on tetracycline partitioning

948

Phase behaviour of oat β-glucan/sodium caseinate mixtures varying in molecular weight

949

Phase behaviour of oxygen adsorbed on graphite

950

Phase Behaviour of Palm Oil Fatty Acid Components in Supercritical Carbon Dioxide

951

Phase behaviour of polymer emulsions during the phase inversion process in the presence of non-ionic surfactants

952

Phase behaviour of pure micellar casein/κ-carrageenan systems in milk salt ultrafiltrate

953

Phase behaviour of RbH2AsO4 above room temperature

954

Phase behaviour of SMMA and SAN blends using Floryʹs equation of state theory

955

Phase behaviour of ternary system styrene–maleic anhydride (SMA) and two styrene–acrylonitrile (SAN) copolymers having different compositions

956

Phase behaviour of the binary mixtures of substituted analogues of LC compounds of the type 4-(4′-substituted phenylazo)-1-naphthyl-4″-alkoxybenzoates

957

Phase behaviour of the binary system ethane+limonene

958

Phase behaviour of the catalyst dicarbonyl(η5-cyclopentadienyl)-cobalt in carbon dioxide

959

Phase behaviour of water+nonionic surfactant systems: experiments and modelling applying the Peng–Robinson equation of state with the Wong–Sandler mixing rules and the UNIQUAC gE-model

960

Phase behaviour study of chalcone in dense CO2

961

Phase behaviour, rheological properties, and microstructure of oat β-glucan-milk mixtures

962

Phase behaviour, rheology and microstructure of mixture of meat proteins and kappa and iota carrageenans

963

Phase bifurcations of electron gas at the conditions of diamagnetic instability

964

Phase Boundaries and Crystallization of Polyethylene in n-Pentane and n-Pentane + Carbon Dioxide Fluid Mixtures

965

Phase boundaries as agents of structural change in macromolecules

966

Phase boundaries of the φ-Al10Cu10Fe1 phase

967

Phase boundary between ilmenite and perovskite structures in MnGeO3 determined by in situ X-ray diffraction measurements

968

Phase Boundary Estimation in Two-Phase Flows with Electrical Impedance Imaging Technique

969

Phase boundary migration, Kirkendall marker shift and atomic mobilities in fcc Au–Pt alloys

970

Phase boundary of dilute lattice spin glasses

971

Phase boundary of pressure-induced I4mm to Cmc21 transition in ammonia borane at elevated temperature determined using Raman spectroscopy

972

Phase boundary of the Zr-rich region in commercial grade Zr–Nb alloys

973

Phase boundary solutions to model kinetic equations via the Conley index theory. Part I

974

Phase boundary solutions to model kinetic equations via the Conley index theory. Part II

975

Phase breaks and chaos in a chain of diffusively coupled oscillators

976

Phase Calibration Technique for Mismatch Optimization in Image-Reject Receivers

977

PHASE CENTRE OPTIMIZATION IN PROFILED CORRUGATED CIRCULAR HORNS WITH PARALLEL GENETIC ALGORITHMS

978

Phase change and electrical resistivity of Zn–Mn–Ni–O-based NTC thermistors produced using IZC powder recycled from used dry batteries

979

Phase change and heat transfer characteristics of a eutectic mixture of palmitic and stearic acids as PCM in a latent heat storage system

980

Phase change and optical band gap behavior of Se0.8S0.2 chalcogenide glass films

981

Phase change behaviour of some latent heat storage media based on calcium chloride hexahydrate

982

Phase change characteristic study of spherical PCMs in solar energy storage

983

Phase change composite based on porous nickel and erythritol

984

Phase change cool storage using dimethyl-sulfoxide

985

Phase change detection of attractive force gradient by using a quartz resonator in noncontact atomic force microscopy

986

Phase change dynamics in a polymer thin film upon femtosecond and picosecond laser irradiation

987

Phase change flattening process for axial grooved heat pipe

988

Phase change heat transfer and bubble behavior observed on twisted wire heater geometries in microgravity

989

Phase change heat transfer device for process heat applications Original Research Article

990

Phase change in calcination process for BaTi2O5 and proposal of a new temperature profile

991

Phase change in porous media

992

Phase change material (PCM) storage for free cooling of buildings—A review

993

Phase change material applications in buildings: An environmental assessment for some Spanish climate severities Original Research Article

994

Phase change material cellulosic composites for the cold storage of perishable products: From material preparation to computational evaluation

995

Phase change material for enhancing solar water heater, an experimental approach

996

Phase change material: Optimizing the thermal properties and thermal conductivity of myristic acid/palmitic acid eutectic mixture with acid-based surfactants

997

Phase change material-based building architecture for thermal management in residential and commercial establishments

998

Phase Change Materials (PCM) microcapsules with different shell compositions: Preparation, characterization and thermal stability

999

Phase change materials based on high-density polyethylene filled with microencapsulated paraffin wax

1000

Phase change materials based on low-density polyethylene/paraffin wax blends